Eucure Biopharma Announces Encouraging Antitumor Activity of I...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
BOSTON and BEIJING, Feb. 4, 2021 /PRNewswire/ -- Eucure Biopharma, a biopharmaceutical company dedicated to developing immuno-oncology antibody drugs, announced that its investigational anti-CD40 antibody drug (YH003), when combined with Junshi Biosciences' anti-PD-1 antibody Toripalimab (TUOYI(...
Authors: LATEST ASIANET NEWS RELEASES